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A B S T R A C T
Tumour necrosis factor alpha (TNF-a) is an innate pro-inﬂammatory cytokine involved in
protection against intracellular pathogens. Existing methods for measuring TNF-a
production and function in ruminants are limited to ELISA and many rely on polyclonal
antisera. With a view to developing improved detection methods for bovine (bov) TNF-a,
monoclonal antibodies (mAb) were produced by immunising mice with a plasmid
encoding bov TNF-a. Two of the resulting mAb, termed CC327 and CC328, were used to
develop a sandwich ELISA capable of detecting both native and recombinant bov TNF-a.
This ELISA did not detect recombinant ovine (ov) TNF-a. A luminometric method was
applied to the ELISA to improve sensitivity for detection of native bov TNF-a in culture
supernatants derived from bovine monocyte-derived dendritic cells (DC) infected with
Mycobacterium bovis. Both CC327 and CC328 detected intracytoplasmic expression of TNF-
a in mitogen-activated bovine T lymphocytes. However, only CC328 detected
intracytoplasmic ovine TNF-a in transfected cells, explaining the failure of the sandwich
ELISA to detect recombinant ov TNF-a. ThesemAbs have generated the capability to study
the role of TNF-a in host immune protection and disease pathogenesis in ruminants.
 2010 Elsevier B.V. All rights reserved.
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journal homepage: www.e lsev ier .com/ locate /vet immThe relative paucity of immunological reagents avail-
able for veterinary species compared to those available for
studies in humans and biomedical species hampers
disease pathogenesis studies and consequently the
development of safe and effective vaccines for animal
species. There remains a need to develop and validate
tools and reagents for bovine (bov) and ovine (ov)
immunology as prioritised through various research
initiatives (Entrican et al., 2009). One such priority is
tumour necrosis factor alpha (TNF-a), a pleiotropic
cytokine that mediates early inﬂammatory responses to
a variety of physical, environmental, and immunological* Corresponding author at: Institute for Animal Health, Immunopathol-
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doi:10.1016/j.vetimm.2010.01.001stimuli. Produced primarily by macrophages and lym-
phocytes, TNF-a coordinates the inﬂammatory response
through the induction of other cytokines (e.g., interleukin
[IL]-1 and IL-6), and through the recruitment of immune
and inﬂammatory cells (Lopez Ramirez et al., 1994; Roach
et al., 2002). In addition, TNF-a is important for immune
control of intracellular bacteria such as Mycobacterium
tuberculosis (Flynn et al., 1995; Havell, 1989; Lin et al.,
2007) and Mycobacterium bovis, the causative agent of
bovine tuberculosis (Denis et al., 2004; Hope et al., 2004).
There are several commercial ELISAs that detect bov TNF-
a, with most (but not all) based on polyclonal antisera.
There are mAb to bov and ov TNF-a available, but
information on their species cross-reactivity, ability to
detect intracytoplasmic TNF-a and to neutralize biologi-
cal activity is limited (Pedersen et al., 2002).
We have previously described the development of mAb
for the detection and measurement of ruminant cytokines
Fig. 1.Detection of TNF-a by sandwich ELISA. (a) Detection of rbov TNF-a
by ELISA using either photometric (open symbols) or luminometric
(closed symbols) readout systems. Threefold dilutions of rbov TNF-a
were titrated in the ELISA. Each standard curve was performed in
duplicate. The OD450 nm was determined using TMB substrate (open
symbols) or luminescent substrate (closed symbols). RLU, relative light
units (closed symbols). (b) Monocyte-derived DC were infected for 24 h
withM. bovis (MOI 1),M. bovis BCG (MOI 10) or were left uninfected (DC).
Supernatants harvested by centrifugation were assessed in the
luminescent ELISA. Units per ml are relative to a standard curve
generated with rbov TNF-a. Mean SD of triplicate wells are indicated.
DC from four animals were assessed and one representative experiment is
shown. Statistical signiﬁcance was determined using Student’s t-test.
**p< 0.01.
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Hope et al., 2002, 2005; Kwong et al., 2002). Using a similar
approach, we describe here the development of mono-
clonal antibodies (mAb) to bov TNF-a and their application
in ELISA and ﬂow cytometric detection systems in both
cattle and sheep. In addition, we describe the neutraliza-
tion capacity of the mAb against bov TNF-a.
Oligonucleotide primers (forward ATGAGCACCA-
AAAGCATGATC, reverse TCACAGGGCGATGATCCCA) were
designed to amplify bov TNF-a (accession number
NM_173966) from bov cDNA. PCR was performed and
the product cloned into pTarget and sequenced by the ABI
Prism automated sequencing method (Oxford University).
Recombinant (r)bov TNF-a was produced by transfecting
COS-7 cells with cDNA encoding bov TNF-a ligated into the
pTarget vector (Promega UK Ltd., Southampton, UK). The
biological activity of rbov TNF-a was determined by
titration in a WEHI-164 cell bioassay (Eskandari et al.,
1990). Serial dilutions of rbov TNF-a ranging from 1/4 to 1/
1,048,576 were added to wells containing 4 104 WEHI-
164 cells. Actinomycin D at 2mg/mlwas also added to each
well. Following 18 h culture, the cells were ﬁxed, stained
with crystal violet and absorbance read at 595 nm. One
unit was deﬁned as the reciprocal dilution which induced
half maximal cell death. To produce mAb, BALB/c mice
were inoculated with the pTarget/bov TNF-a construct on
four occasions 1 month apart. Seroconversion was
assessed by screening on ELISA plates coated with 50 U/
ml rbov TNF-a. Binding of mAb was detected with goat
anti-mouse Ig biotin and strepavidin-HRP (SA-HRP)
(Amersham Pharmacia Biotech, Uppsala, Sweden).
3,30,5,50-Tetramethylbenzidine (TMB, Sigma–Aldrich,
Poole, UK) was used as a substrate. Four weeks after the
fourth injection, mice that had seroconverted were
inoculated intraperitoneally with a ﬁnal boost of TNF-a
plasmid. Spleens were removed three days and fused with
SP2/0 cells as previously described (Jones and Howard,
1995). Supernatants from wells containing hybridomas
were tested for mAb reactivity to rbov TNF-a by ELISA as
described above. Hybridomas were cloned by limiting
dilution. Two mAb, termed CC327 (IgG2b) and CC328
(IgG2a), were selected for further characterization. These
hybridomas were cultured in a MinipermTM (Sartorius,
Goettingen, Germany) and IgG puriﬁed from supernatants
by passage through a Sepharose protein G column and
transferred to PBS by passage through a PD10 desalting
column (Amersham Pharmacia Biotech). Ig was coupled to
biotin using NHS-biotin or NHS-long chain-biotin accord-
ing to the manufacturer’s instructions (Pierce, Rockford,
USA). The control mAb usedwere AV29 (mouse IgG2b) and
AV37 (mouse IgG2a), which are directed against chicken
CD4+ cells and chicken spleen cell subset, respectively.
ThesemAbwere kindly provided by Dr. C. Butter (IAH) and
have been previously described for use as isotype control
mAb in cattle studies (Hope et al., 2002). To develop a
sandwich ELISA, CC327 and CC328 were tested by
checkerboard assay for detection of both recombinant
and native bov TNF-a. This was performed as described
previously for other mAb (Hope et al., 2002, 2005; Kwong
et al., 2002). Optimal detection of rbov TNF-a was
observed using CC327 as coating mAb at 2mg/ml andCC328-biotin as detection mAb at 1mg/ml. Photometric
and luminometric readout systems were applied as
previously described (Hope et al., 2002; Hope et al.,
2005; Kwong et al., 2002). TNF-a concentrations in
samples were determined in comparison with a standard
curve comprising serial dilutions of rbov TNF-a. Concen-
trations were expressed as biological units per ml (U/ml).
The background level of luminescence (relative light units,
RLU) or optical density (OD) in wells with only blocking
buffer (PBS-casein) was between 5 and 10 RLU and 0.02–
0.05 OD units, respectively. Typical titration curves from
the photometric ELISA are shown in Fig. 1a (open
symbols), where the limit of detection of rbov TNF-a
was approximately 0.05 U/ml. The linear working range of
the standard photometric ELISA was 0.05–3.7 U/ml.
Comparable detection limits and linear ranges were
observed in a number of experiments where luminometric
and photometric ELISA detection systems were assessed in
Fig. 2.Neutralization of TNF-a bioactivity by anti-bovine TNF-amAb. The
capacity of CC327 (a) and CC328 (b) to neutralize TNF-a-induced
cytotoxicity of WEHI-164 cells was assessed. Isotype- and concentration-
matched control antibodies AV29 and AV37were also assessed in parallel.
Serial dilutions of mAb from 10mg/ml were added to TNF-a-treated
WEHI cells and the level of TNF-a-induced cytotoxicity was assessed 18 h
later. Means of triplicate wells are illustrated. Statistical signiﬁcance was
determined using Student’s t-test. Signiﬁcant (p< 0.05) reductions in
TNF-a induced cytotoxicity were observed with CC328 at all
concentrations between 10 and 0.31mg/ml, and with CC327 at
concentrations between 10 and 0.63mg/ml, when compared to isotype
and concentration-matched control mAb.
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During these experiments, a commercially available ELISA
for bov TNF-a became available (Pierce-Endogen, Rock-
ford, IL, USA). Comparing our material with that ELISA, 1 U
of COS cell expressed rbov TNF-a was found to be
equivalent to 500 pg, indicating a detection limit of
approximately 25 pg/ml and an upper range of 5000 pg/
ml for the CC327/CC328 ELISA. Interestingly, this ELISA
failed to detect rov TNF-a expressed in Chinese Hamster
Ovary (CHO) cells, although the Pierce-Endogen ELISA did
(data not shown). The rov TNF-a was derived from CHO
cells transfected with cDNA encoding ovine TNF-a ligated
into in the pEE141 expression vector (Lonza Biologics plc,
Slough, UK) according to previously published protocols
(Entrican et al., 1996).
The capability of the CC327/CC328 ELISA to detect
native bov TNF-a was assessed using supernatants from
bovine monocyte-derived dendritic cells (DC) infected
withM. bovis orM. bovis BCG for 24 h (Hope et al., 2004).
Brieﬂy, bovine DC were isolated and cultured overnight
with M. bovis AF2122 (Garnier et al., 2003) at a
multiplicity of infection (MOI) of 1, or with BCG Pasteur
(Hope et al., 2000) at MOI of 10. Supernatants removed
24 h later were assessed by ELISA using luminometric
readout (Fig. 1b). Signiﬁcantly higher levels of TNF-a
were secreted from DC infected with M. bovis compared
to BCG (p< 0.01), or from control, uninfected DC
(Fig. 1b).
The capacity of CC327 and CC328 to neutralize the
biological activity of rbov TNF-awas assessed by bioassay
usingWEHI-164 cells as described above (Fig. 2). Doubling
dilutions of puriﬁed CC327 and CC328 ranging from 10 to
0.04mg/ml, plus isotype- and concentration-matched
control mAb (AV29 and AV37), were added to wells
containing 4 104 WEHI-164 cells in the presence of rbov
TNF-a (4 U/ml) for 18 h. In the absence ofmAb, rbov TNF-a
induced greater than 60% cell death. In the presence of
either CC327 or CC328 signiﬁcantly lower levels of TNF-a
induced cell death were observed (p< 0.05; Fig. 2)
indicating that both mAb neutralized the biological
activity of rbov TNF-a (Fig. 2). Overall, CC328 was more
effective (Fig. 2b), neutralizing TNF-a bioactivity over a
wider range of mAb concentrations when compared to
CC327 (Fig. 2a).
To detect intracytoplasmic TNF-a, bov peripheral blood
mononuclear cells (PBMC) were stimulated for 4.5 h with
PMA (50 ng/ml) and ionomycin (1mg/ml) in the presence
of brefeldin-A (10mg/ml) (all Sigma–Aldrich, Poole, UK).
The stable, cloned transfected CHO cell line described
above was used for intracytoplasmic detection of ov TNF-
a. In all cases, intracytoplasmic expression of TNF-a was
assessed by ﬂow cytometric analysis of ﬁxed and
permeabilised cells as previously described (Hope et al.,
2002, 2005). Isotype-matched control mAb (AV29 and
AV37) were included at concentrations that matched
CC327 and CC328. Goat anti-mouse Ig isotype speciﬁc, FITC
labelled, secondary reagents (Southern Biotec, Birming-
ham, AL, USA) were used. Intracytoplasmic bov TNF-awas
detected with both CC327 (Fig. 3a) and CC328 (Fig. 3b). A
different pattern of expression was observed between the
mAb,with CC327 detecting a larger proportion of cells thanCC328. Only mAb CC328 was able to detect intracyto-
plasmic expression of ov TNF-a (Fig. 3d), there was no
evidence for cross-reactivity of CC327 with ov TNF-a
(Fig. 3c). This explains the failure of the sandwich ELISA to
detect ov TNF-a, despite a predicted 90% amino acid
similarity between bov and ov TNF-a (McInnes et al.,
1997). Although this ELISA does not detect ovine TNFa, and
CC327 does not detect intracellular ovine TNFa by ﬂow
cytometry, this mAb has been reported to detect ovine
TNFa in ﬁxed tissues, which may be a result of epitope
conformational change on ﬁxation (Wheelhouse et al.,
2009).
In summary, we have developed a sandwich ELISA for
detection of bovine TNF-a and demonstrate the capability
of CC328 to detect intracytoplasmic bovine and ovine TNF-
a, thereby providing experimental capability to assess the
role of this cytokine in ruminant immunity and disease
pathogenesis.
Fig. 3. Detection of intracytoplasmic TNF-a. Bovine PBMC (a and b) were stimulated for 4.5 h with PMA and ionomycin in the presence of brefeldin-A.
Transfected CHO cells were used for detection of ovine TNF-a: (c and d) intracytoplasmic TNF-a was detected by ﬂow cytometry using mAbs, (a and c)
CC327 and (b and d) CC328. Isotype-matched control mAb (red overlays) was AV29 and AV37, respectively. Live cells were gated and results were analyzed
using FCS Express software (De Novo Software, Ontario, Canada). (For interpretation of the references to color in this ﬁgure caption, the reader is referred to
the web version of the article.)
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